×

Regenerative Medicine Market Set to Register 12.8% CAGR due to Rising Tissue Engineering and Stem Cell Therapy: Transparency Market Research

Albany, NY, Nov. 25, 2015 (GLOBE NEWSWIRE) -- According to Transparency Market Research's new market research report, titled 'Regenerative Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019', the global regenerative medicine market is driven by several technological advancements in stem cell therapy and tissue engineering therapy. Such growth factors are expected to push the market from a value of US$2.6 billion in 2012 to US$6.5 billion by 2019. Overall, the market is expected to grow at a CAGR of 12.8% from 2013 to 2019.

Browse the full Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/regenerative-medicines-market.html

The study report provides a complete snapshot of the global regenerative medicine market by technology, applications, and geography for the forecast period from 2012 to 2019. Under the overview section, the study defines regenerative medicine as a solution to regenerate, repair, or replace damaged tissue and organs in the body. Regenerative medicine is an emerging field of medical science and has wide areas of application such as musculoskeletal diseases, cardiovascular, neurology, orthopedic, and disorders. Besides technological advancements in the global regenerative medicine market, the growing prevalence of bone and joint disorders has also increased demand from the regenerative medicine market rapidly across the globe. This factor has substantially propelled the global regenerative medicine (bone and joint) market.

Get Sample Report Copy of Regenerative Medicine Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

Based on technology, the global market for regenerative medicine is segmented as stem cell therapy, biomaterials, and tissue engineering. The report states that in 2012, due to the favorable reimbursement policies and strong demand for biomaterials, the biomaterials segment took up the largest share of the global regenerative medicine (bone and joint) market. However, according to the studies, high cost associated with biomaterials will be a major factor expected to restrict the global regenerative medicine market over the forecast period. In addition, tissue engineering is expected to grow at a rapid pace until 2019. Growth of this segment is expected to occur at the highest CAGR from 2013 to 2019.

Browse Press Release of Regenerative Medicine Market: http://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.htm

By applications, the global market for regenerative medicine (bone and joint) is segmented into allogeneic bones, bone graft substitute, autogenic bones, osteoarticular diseases, and others. Owing to increasing demand for bone graft substitutes in orthopedic surgeries, the bone graft substitutes segment held the largest share of the global regenerative medicine market in 2012. TMR analysts state that post-implantation rejection associated with bone graft substitute methods is considered to be a key factor that would restrict the demand for bone graft substitutes across various regions.

Browse Article of Regenerative Medicine Market: http://www.transparencymarketresearch.com/article/regenerative-medicines-market.htm

Moreover, the study report enlists some of the major market players in the global regenerative medicine (bone and joint) market. These include Medtronic, Inc. (INFUSE Bone Graft), Zimmer Holdings, Inc., Orthofix, Inc. (Trinity Evolution), DePuySynthes, Inc., and NuVasive, Inc. (Osteocel Plus).Many of the companies operating in the regenerative medicine market focus on investing in the emerging economies in Asia Pacific, such as Japan, China, India, and South Korea. These countries represent a huge potential for various bone and joint reconstructive products because of the increasing patient pool suffering from various disorders and rising healthcare expenditure.

Browse Upcoming Market Research Reports:

Life Sciences Tools Market: http://www.transparencymarketresearch.com/life-sciences-tools.html

Biotech API Manufacturing Services Market: http://www.transparencymarketresearch.com/biotech-api-manufacturing-services.html

Biological Machines Market: http://www.transparencymarketresearch.com/biological-machines-market.html

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering

Regenerative Medicine (Bone and Joint) Market, by Application

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones
  • Others

Regenerative Medicine (Bone and Joint) Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Other Related Reports Published by Transparency Market Research:

Bone Grafts and Substitutes Market expected to reach USD 3.48 Billion globally in 2023

The global bone grafts and substitutes (BGS) market has been categorized into allografts and bone graft substitutes. The allografts segment includes demineralized bone matrix (DBM) and other allografts (freeze-dried bone and fresh frozen bone). The bone graft substitutes segment has been further classified into synthetic bone grafts, bone morphogenetic protein (BMP), and others.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6200

Dental Bone Graft Substitutes and other Biomaterials Market to reach US$0.88 Million by 2020

The report analyzes the global market for dental bone graft substitutes and other biomaterials on the basis of materials utilized and the regional distribution of this market.Based on the materials, the report marks the market for natural bone graft substitutes as the market leader in 2013 in terms of revenue generated. However, analysts at TMR expect the market segment for ceramics to expand at the highest CAGR over the forecast period. Additionally, continual research and development by various market players to produce advanced ceramic products utilized for dental grafting is expected to fuel the ceramics market significantly in the future.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1824

Browse All Other Biotechnology Market Research Reports: http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html

About Us:

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

CONTACT: Mr. Nachiket Ghumare 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/

Source:Transparency Market Research